Gluconeogenesis is the biosynthesis of glucose from non-carbohydrate precursors. It is essentially the reverse of glycolysis, occurring primarily in the liver and kidneys during fasting, starvation, or intense exercise.
How Gluconeogenesis Works
Precursors
The main precursors for gluconeogenesis are lactate (from anaerobic glycolysis in muscle), amino acids (especially alanine from muscle protein breakdown), and glycerol (from fat breakdown). These molecules enter the pathway at various points.
Bypassing Irreversible Steps
Glycolysis has three irreversible steps that must be bypassed in gluconeogenesis, catalyzed by different enzymes. Pyruvate is converted to oxaloacetate by pyruvate carboxylase, then to phosphoenolpyruvate by PEP carboxykinase (bypassing pyruvate kinase). Fructose-1,6-bisphosphate is converted to fructose-6-phosphate by fructose-1,6-bisphosphatase (bypassing PFK-1). Glucose-6-phosphate is converted to glucose by glucose-6-phosphatase (bypassing hexokinase).
Energy Cost
Gluconeogenesis is energetically expensive. Synthesizing one molecule of glucose requires 4 ATP, 2 GTP, and 2 NADH.
Regulation
Gluconeogenesis and glycolysis are reciprocally regulated to prevent a futile cycle. When energy is abundant, glycolysis is inhibited and gluconeogenesis is activated. The hormones glucagon and cortisol stimulate gluconeogenesis, while insulin inhibits it.
The Cori Cycle
During intense exercise, muscles produce lactate through anaerobic glycolysis. The lactate is released into the blood and taken up by the liver, which converts it back to glucose via gluconeogenesis. The glucose returns to the muscles, completing the Cori cycle.
Practical Measurement of Gluconeogenic Flux
Gluconeogenic flux in primary hepatocytes is measured by incubating cells with ¹⁴C-labeled precursors such as [2-¹⁴C]pyruvate, [U-¹⁴C]lactate, or [¹⁴C]alanine. Plate primary rat hepatocytes at 1 × 10⁶ cells/well in a 12-well plate in serum-free DMEM without glucose. After 2 hours of starvation, replace the medium with Krebs-Ringer bicarbonate buffer containing 2 mM each of lactate, pyruvate, and alanine (gluconeogenic precursors) plus 0.5 µCi/mL of [¹⁴C]labeled substrate. Incubate for 3 hours at 37°C under 5% CO2. Stop the reaction by adding ice-cold perchloric acid (final 3%). Isolate radiolabeled glucose by ion-exchange chromatography — pass the neutralized supernatant through a column of Dowex-1 (acetate form) to retain labeled intermediates, then elute glucose with water. Count the eluted glucose by liquid scintillation. Express gluconeogenic flux as nmol glucose produced per mg protein per hour. Include a control with 10 µM of the gluconeogenesis inhibitor 3-mercaptopicolinate (inhibits PEP carboxykinase) to confirm pathway specificity. For isolated perfused liver, measure net glucose output by assaying glucose in the perfusate using a glucose oxidase assay kit.
Real-World Application
In type 2 diabetes research, gluconeogenic flux is elevated due to insulin resistance. Hepatocytes from diabetic db/db mice show a 2.5-fold increase in glucose production from [¹⁴C]lactate compared to wild-type controls. Metformin treatment (1 mM, 24 hours) reduces this flux by 40%, consistent with its clinical mechanism of suppressing hepatic gluconeogenesis. These measurements guide the development of new therapeutics for glycemic control.
